06/04/2019
BCBSM/BCN
Publications
June 2019 – Issue
- New care management program to launch in 2020
- SCIO Health Analytics auditing outpatient claims for commercial business
- HCPCS update: New codes added
- Billing chart: Blues highlight medical, benefit policy changes
- New Payable Procedures Include: J9999 - Libtayo (cemiplimab-rwlc), J3590 - JIVI (antihemophilic factor [recombinant] Pegylated-aucl), J9171 - Docefrez (docetaxel), J9271 - Keytruda (pembrolizumab)
- You must use network laboratories for your Blue Cross and BCN patients
- Medicare Part B medical specialty drug prior authorization list changing
- Here’s helpful information about clinical editing appeals for Blue Cross PPO and Medicare Plus Blue claims
CHECK OUT THESE ARTICLES AND MUCH MORE HERE!
A Few Articles You Won’t Want to Miss:
- Here’s how to confirm the networks you participate in
- Medical record guidelines policies require providers to maintain member records
- Inflectra to be the preferred infliximab product for adult BCN Commercial members
- AIM Specialty Health to manage medical oncology medications for BCN starting August 1
- We’ve made additional changes to the peer-to-peer review process
And Much More…MAY/JUNE Bi-Monthly Issue Available HERE